Skip to content
TrialScanner

NCT06915766

Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis

No phase registeredAvailableCOGTLead

Registry record

Lead sponsor
Cogent Biosciences, Inc.
Conditions
Systemic Mastocytoses, Indolent; Systemic Mastocytoses, Aggressive
Primary completion
Not registered
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06915766 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT06915766: Expanded Access to Bezuclasti... | TrialScanner